XML 43 R31.htm IDEA: XBRL DOCUMENT
v3.26.1

Stock Options (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Stock Options and Restricted Stock |
Summary of weighted average assumptions used in the model for valuing stock option grants | The weighted average assumptions used in the model for valuing stock options grants for the three months ended March 31, 2026 are as follows: ​
​ | ​ | ​ | ​
​ | ​ | March 31, | ​
​ | ​ ​ ​ | 2026 | ​ ​ ​
Dividend Yield |  | — | %
Expected Life |  | 7 | Years
Expected Volatility |  | 30.92 | %
Risk-Free Interest Rate |  | 3.95 | %
Summary of the status of the Company's outstanding stock options | ​ The following table presents a summary of the status of the Company’s outstanding stock options for the three months ended March 31, 2026: ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, 2026
​ | ​ ​ ​ | ​ ​ ​ | ​ ​ ​ | Weighted
​ | ​ | ​ | ​ | Average
​ | ​ | Shares | ​ | Exercise Price
Outstanding at Beginning of Year |  | 1,935,175 | ​ | $ | 11.59
Granted |  | 25,000 | ​ |  | 17.53
Exercised |  | (30,400) | ​ |  | 10.70
Forfeitures |  | — | ​ |  | —
Outstanding at Period End |  | 1,929,775 | ​ | $ | 11.68
​ | ​ | ​ | ​ | ​ | ​
Options Exercisable at Period End |  | 1,460,524 | ​ | $ | 11.17
Summary of information pertaining to options outstanding based on range of exercise price | The following table presents information pertaining to options outstanding at March 31, 2026: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Options Outstanding | ​ | Options Exercisable
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted Average | ​ | ​ | ​ | ​
​ | ​ | ​ | Number of | ​ | Weighted Average | ​ | Remaining Contractual | ​ | Number of | ​ | Weighted Average
Range of Exercise Prices | ​ ​ ​ | Options | ​ ​ ​ | Exercise Price | ​ | Life in Years | ​ | Options | ​ ​ ​ | Exercise Price
$ | 7.00 - 7.99 |  | 642,392 |  | $ | 7.47 |  | 1.5 |  | 642,392 |  | $ | 7.47
​ | 8.00 - 8.99 |  | 2,961 |  | ​ | 8.76 |  | 4.0 |  | 2,961 |  | ​ | 8.76
​ | 10.00 - 10.99 | ​ | 190,000 | ​ | ​ | 10.65 | ​ | 7.3 | ​ | 82,249 | ​ | ​ | 10.65
​ | 11.00 - 11.99 | ​ | 203,625 | ​ | ​ | 11.17 | ​ | 6.0 | ​ | 130,875 | ​ | ​ | 11.21
​ | 12.00 - 12.99 | ​ | 245,297 | ​ | ​ | 12.91 | ​ | 3.3 | ​ | 245,297 | ​ | ​ | 12.91
​ | 13.00 - 13.99 | ​ | 285,000 | ​ | ​ | 13.75 | ​ | 8.8 | ​ | 71,250 | ​ | ​ | 13.75
​ | 17.00 - 17.99 | ​ | 310,500 | ​ | ​ | 17.50 | ​ | 6.2 | ​ | 285,500 | ​ | ​ | 17.50
​ | 18.00 - 18.99 | ​ | 50,000 | ​ | ​ | 18.03 | ​ | 9.7 | ​ | — | ​ | ​ | —
​ | Totals |  | 1,929,775 | ​ | $ | 11.68 | ​ | 4.8 |  | 1,460,524 | ​ | $ | 11.17
Summary of analysis of nonvested options to purchase shares of the Company's stock issued and outstanding | The following table presents an analysis of nonvested options to purchase shares of the Company’s stock issued and outstanding for the three months ended March 31, 2026: ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | ​ ​ ​ | ​ ​ ​ | Weighted
​ | ​ | Number of | ​ | Average Grant
​ | ​ | Shares | ​ | Date Fair Value
Nonvested Options at December 31, 2025 |  | 584,251 | ​ | $ | 5.69
Granted |  | 25,000 | ​ | ​ | 7.24
Vested |  | (140,000) | ​ | ​ | 5.55
Forfeited | ​ | — | ​ | ​ | —
Nonvested Options at March 31, 2026 |  | 469,251 | ​ | $ | 5.82
Summary of the status of the Company's outstanding restricted stock units | The following table presents an analysis of nonvested restricted stock units outstanding for the three months ended March 31, 2026:
​ | ​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | ​ ​ ​ | ​ ​ ​ | Weighted
​ | ​ | Number of | ​ | Average Grant
​ | ​ | Units | ​ | Date Fair Value
Nonvested at December 31, 2025 |  | 447,661 | ​ | $ | 15.24
Granted |  | 64,419 | ​ | ​ | 19.54
Vested |  | (50,373) | ​ | ​ | 13.93
Forfeited | ​ | (1,421) | ​ | ​ | 18.05
Nonvested at March 31, 2026 |  | 460,286 | ​ | $ | 15.97

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration